Clearmind Medicine, Inc. 是一家迷幻药物制药生物技术公司。公司总部位于不列颠哥伦比亚省温哥华。该公司于2021年8月10日上市。公司专注于开发新型迷幻药衍生治疗药物,以解决普遍存在的且未得到充分治疗的健康问题,包括酒精使用障碍。公司研究和开发基于迷幻药的化合物,并尝试将它们作为受监管的药品、食品或补充剂进行商业化。公司的知识产权组合包括15个专利家族,其中包括27项已授权专利和24项待审申请。该组合覆盖多个司法管辖区,包括美国、欧洲、印度和中国。
CMND stock price ended at $1.13 on 星期五, after rising 3.67%
On the latest trading day Feb 13, 2026, the stock price of CMND rose by 3.67%, climbing from $1.09 to $1.13. Throughout the session, the stock experienced a volatility of 3.67%, with prices fluctuating between a daily low of $1.09 and a high of $1.13. Alongside this price increase, trading volume also rose by 22.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 19.2K shares were traded, amounting to a market value of approximately $67.7M.